Parkinson’s News Today

October 19, 2021October 19, 2021

Mission Earns MJFF Grant to Develop Familial Parkinson’s Treatment

Mission Therapeutics has been awarded a Therapeutic Pipeline Program grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to advance development of its USP30 deubiquitylating enzyme (DUB) inhibitors for the treatment of familial Parkinson’s disease. ... Read more

October 19, 2021October 19, 2021

New DBS Protocol Has Lasting Effects in Mice

Parkinson's News Today

A deep brain stimulation (DBS) protocol that targets specific sets of nerve cells, or neurons, in the brain produced long-lasting effects in a mouse model of Parkinson’s disease. The new protocol, which uses ... Read more

October 18, 2021October 18, 2021

Reopened Udall Center at U-M Will Study Falls, Cognitive Impairment

Parkinson's News Today

The University of Michigan (U-M) will use a five-year, $11.7 million grant to reopen its Morris K. Udall Center of Excellence in Parkinson’s Disease Research, according to a university press release. ... Read more

October 18, 2021October 18, 2021

Study Exploring Why Alpha-synuclein Hurts Some Cells But Not Others

Parkinson's News Today

A new research project seeks to better characterize the structural properties of alpha-synuclein, which researchers hope will lead to a better understanding of this protein’s toxic effects in Parkinson’s disease. ... Read more

October 15, 2021October 15, 2021

Epilepsy Therapy Zonisamide Found to Reduce Parkinson’s ‘Off’ Time

Parkinson's News Today

Treatment with zonisamide — an approved epilepsy medication — can reduce “off” time without worsening treatment side effects in people with Parkinson’s disease, a new analysis of Japanese clinical trial ... Read more

October 15, 2021October 15, 2021

HealthWell Opens Fund to Help Parkinson’s Patients With Psychosis

Parkinson's News Today

The HealthWell Foundation has opened a fund to support people with Parkinson’s or other neurocognitive diseases in the U.S. who also are being treated for psychosis. To be eligible, patients ... Read more

October 14, 2021October 14, 2021

Supernus to Acquire Adamas and Its Therapies, Gocovri and Osmolex ER

Parkinson's News Today

Two established Parkinson’s disease (PD) treatments — Gocovri (amantadine) and Osmolex ER (amantadine hydrochloride) — will move to Supernus’ Pharmaceuticals when it completes an agreement now in place for it to acquire ... Read more

October 14, 2021October 14, 2021

Extended Dosing Improves Safety of IkT-148009, Animal Studies Show

Parkinson's News Today

The safety profile of IkT-148009, an investigational oral medication for Parkinson’s disease, improved the longer the drug was dosed, demonstrating target selectivity, according to interim three-month animal data. The ongoing ... Read more

October 13, 2021October 13, 2021

MJFF Details Need for Diversity in Parkinson’s Research, Care

Parkinson's News Today

Current understanding of Parkinson’s disease does not reflect patients from diverse socioeconomic or ethnic backgrounds, and they remain poorly represented in research, according to a position paper from The Michael ... Read more

October 13, 2021October 13, 2021

Partnership to Expand Prescription Music Catalog for Walking Therapy

COVID-19 News, Parkinson's News Today

MedRhythms, which is pioneering rhythmic auditory stimulation to improve walking ability in people with neurological disorders, has now launched a partnership with Universal Music Group (UMG) — owner of a vast ... Read more

October 12, 2021October 12, 2021

Parkinson’s Voice Project’s Annual Virtual Choir Concert Set for Nov. 6

Parkinson's News Today

The Parkinson Voice Project (PVP) is hosting its second annual Parkinson’s Virtual Choir Concert on Nov. 6, with more than 300 Parkinson’s disease patients from around the world and their family ... Read more

October 12, 2021October 13, 2021

Study of Keyboard Typing as Way of Monitoring Motor Skills Planned

Parkinson's News Today

nQ Medical and EvergreenHealth are looking for people with early stage Parkinson’s disease to enter a monthlong study of a software tool — known as neuroQWERTY — to help track motor symptoms by monitoring how ... Read more

October 11, 2021October 11, 2021

Immune Cells Found to Cooperate to Fight Toxic Protein Clumps

Parkinson's News Today

Immune cells in the brain responsible for breaking down the toxic protein clumps, or aggregates, that lead to nerve cell death in Parkinson’s disease join together to form networks to ... Read more

October 11, 2021October 11, 2021

GCase Enzyme Activity Not Linked to Parkinson’s Risk, Severity

Parkinson's News Today

The activity of the enzyme glucocerebrosidase, called GCase, is not tied to the risk of developing Parkinson’s, nor linked with the disease’s severity, a new analysis from Israel indicates. “We ... Read more

October 8, 2021October 8, 2021

Hartford Healthcare Awarded 2021 ‘Speak Out!’ Crowd Grant

Parkinson's News Today

Hartford Healthcare has been awarded a Parkinson Voice Project 2021 SPEAK OUT! & LOUD Crowd grant — which the Connecticut healthcare network will use to expand its speech therapy programs. ... Read more